New American Perspectives: Spotlight on Foreign-Born Filmmakers at HIFF
November 07, 2022 12:01 ET
|
The Vilcek Foundation
NEW YORK, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The Vilcek Foundation will present the New American Perspectives program at the 42nd Annual Hawai'i International Film Festival (HIFF) in Honolulu this...
aTyr Pharma to Present at the Jefferies London Healthcare Conference
October 25, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 25, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
Life Cycle Assessment Software Market Projected to Surpass 737.69 million USD and Grow at a 15.62% CAGR During the 2022-2027 Forecast Timeframe [ 123 Pages Report]
October 20, 2022 06:43 ET
|
Proficient Market Insights
Pune, Oct. 20, 2022 (GLOBE NEWSWIRE) -- "Life Cycle Assessment Software Market" size was valued at USD 308.81 million in 2021 and is expected to expand at a CAGR of 15.62% during the forecast...
Ress Life Investments A/S: Ress Life Investments A/S publishes portfolio composition
October 19, 2022 03:25 ET
|
Ress Life Investments A/S
Ress Life Investments A/SHolbergsgade 14, 2 tvDK-1057 Copenhagen KDenmarkCVR nr. 33593163resslifeinvestments.comTo: Nasdaq CopenhagenDate: 19 October 2022 Corporate Announcement 37/2022 ...
aTyr Pharma Announces Research Collaboration with Dualsystems Biotech AG to Identify 10 New Therapeutic Targets
October 11, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 11, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or “the Company”), a biotherapeutics company engaged in the discovery and development of first-in-class medicines...
aTyr Pharma to Participate in RBC Biotech Expert Insights: Pulmonary/Lung Disease Mini-Symposium
October 04, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
aTyr Pharma Announces Notice of Allowance for U.S. Patent for Anti-Neuropilin-2 (NRP2) Monoclonal Antibodies
September 29, 2022 08:00 ET
|
aTyr Pharma, Inc.
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
September 27, 2022 08:00 ET
|
aTyr Pharma, Inc.
Multiple centers in the U.S. are open for enrollment for double-blind, randomized, placebo-controlled study. Primary endpoint will evaluate steroid-sparing effect of efzofitimod compared to placebo. ...
Experience a Pirate’s Life in Multiplayer Arcade Brawler Plunder Panic, Out Now With Crossplay Between All Major Consoles and Windows PC/Mac
September 16, 2022 10:00 ET
|
Will Winn Games
EAST LANSING, Mich., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Ahoy, Me Hearties! Hoist the Jolly Roger and sharpen those cutlasses, as Will Winn Games’ pirate-themed online multiplayer brawler Plunder...
aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod for Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
September 13, 2022 08:00 ET
|
aTyr Pharma, Inc.
Second Fast Track designation for efzofitimod clinical program. Efzofitimod previously received FDA orphan drug designation for systemic sclerosis (SSc). SAN DIEGO, Sept. 13, 2022 (GLOBE NEWSWIRE)...